CompletedNot Applicable

Impact of Perioperative Allogeneic Red Blood Cell Transfusion on Postoperative Myocardial Injury After Liver Resection

487 participantsStarted 2016-01-01

Plain-language summary

We aimed to explore the influence of ABT on the incidence of MINS, AKI, and overall prognosis among advanced-age HCC patients who underwent hepatectomy

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients over 65 years with HCC undergoing elective surgery between January 2016 and December 2018 Exclusion Criteria: ASA grade V requiring repeat surgery within 1 week losing to follow-up and/or those with \>5% missing data

What they're measuring

the incidence of MINS within postoperative 30 days

Timeframe: postoperative day 1-30

Trial details

NCT IDNCT07125612

SponsorHao Li

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-12-31

View on ClinicalTrials.gov More Myocardial Injury trials